Addex Therapeutics (ADXN) Revenue (2019 - 2025)

Addex Therapeutics has disclosed Revenue across 7 years of filings, most recently posting $310.29 for Q4 2025.

• In Q4 2025, Revenue fell 81.97% year-over-year to $310.29; the TTM figure through Dec 2025 stood at $39190.0 (down 91.46% YoY), while the FY2025 annual figure was $36150.1, down 92.13% from the prior year.
• Revenue came in at $310.29 for Q4 2025 at Addex Therapeutics, down from $37158.3 in the prior quarter.
• In the past five years, Revenue ranged from a high of $3.4 million in Q4 2021 to a low of $310.29 in Q4 2025.
• Average Revenue over 5 years is $553010.1, with a median of $319268.8 recorded in 2024.
• Year-over-year, Revenue jumped 2407.84% in 2021 and sank 99.0% in 2024.
• Over 5 years, Revenue stood at $3.4 million in 2021, then slumped by 82.02% to $614955.3 in 2022, then sank by 71.87% to $172993.7 in 2023, then slumped by 99.0% to $1721.4 in 2024, then sank by 81.97% to $310.29 in 2025.
• Per Business Quant data, the three most recent Revenue figures were $310.29 in Q4 2025, $37158.3 in Q3 2025, and $1721.4 in Q4 2024.